We have cloned and characterized a gene cluster for anthracycline biosynthe
sis from Streptomyces galilaeus. This cluster, 15-kb long, includes eight g
enes involved in the deoxyhexose biosynthesis pathway, a gene for a glycosy
ltransferase and one for an activator, as well as two genes involved in agl
ycone biosynthesis. Gene disruption targeted to the activator gene blocked
production of aclacinomycins in S. galilaeus. Plasmid pSgs4, containing gen
es for a glycosyltransferase (aknS), an aminomethylase (aknX), a glucose-1-
phosphate thymidylyltransferase (aknY) and two genes for unidentified glyco
sylation functions (nknT and aknV), restored the production of aclacinomyci
ns in the S. galilaeus mutants H063, which accumulates aklavinone, and H054
, which produces aklavinone with rhodinose and deoxyfucose residues. Furthe
rmore, pSgs4 directed the production of L-rhamnosyl-epsilon-rhodomycinone a
nd L-daunosaminyl-epsilon-rhodomycinone in S. peucetius strains that produc
e epsilon-rhodomycinone endogenously. Subcloning of the gene cluster was ca
rried out in order to further define the genes that are responsible for com
plementation and hybrid anthracycline generation.